Global expert survey reveals how regulation can help or hurt crop gene-editing innovation

regulation
Credit: Shutterstock
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The adoption of genome editing depends among others, on a clear and navigable regulatory framework that renders consistent decisions. Some countries like the United States decided to deregulate specific transgene-free genome edited products that could be created through traditional breeding and are not considered to be plant pests, while others are still challenged to fit emerging technologies in their regulatory system.

Here we poll international experts in plant biotechnology on what approach should nations agree upon to accommodate current and future new breeding technologies and derived products. A key finding is product-based models or dual-product/process systems are viewed as potential appropriate frameworks to regulate outcomes of genome editing. As regulation of novel products of biotechnology is expected to impact research and trade, we test the impact of experts’ worldviews on these issues. Results show that region influences worldviews of trade but not of agricultural innovation. In contrast, there was no effect of experts’ worldviews on how products of novel biotechnologies should be regulated.

The survey was completed by 113 participants, resulting in a response rate of 23.6%. The panel is dominated by males (80%), aged between 45 and 65 years (70%). Forty-one of the participants reside in North America (NA), 34% in Europe, and 25% are from the rest of the world (ROW: 5% in Africa, 5 % in Asia, 6% in Oceania and 9% in Central and South Americas).

The majority of respondents hold a PhD degree (71%) and 20% have a masters’ degree. Forty percent work for industry, 26% for a university, and 20% in government. Seventy-one percent identified themselves as scientific experts, and 29% as social experts (lawyers, agribusiness professionals, etc.). When asked about their frequency of engagement in regulatory activities, 44% reported they are often or almost always engaged during the course of their work, 46% are occasionally involved (Sometimes: 28%, Rarely: 18%) and 10% are almost never involved in such tasks. Engaging in regulatory activities include providing input data (24%) and/or input analysis (32%), contributing to decision-making (25%) and rule-making (15%).

Related article:  What the CRISPR babies can teach us about the failings of ethical oversight

For many participants, the outcome of a technology (either crop type or end-product) matters the most for farmers and consumers as it is the use that determines how risky or valuable a new trait actually is. Experts generally agree that the final product—regardless of how it is developed—can generate potential risks. Experts further agree that each trait should be comprehensively characterized, including its social impact, ethical considerations and sustainability One justification is that the process-based system may be unable to keep pace with emerging technologies. One view is that a product-based safety assessment is the “only scientifically valid approach”.

One respondent stated that: “Focusing on the process, in transgenesis, has led to bad decision-making, especially in Europe, and groundless fears in parts of the general public.” Another added: “The process can be performed under controlled settings and thus any risk mitigated at the site of execution of the process. Products are released to the public… it makes most sense to regulate what reaches the public.” According to one expert, a product-based approach would help overcome the problem of defining a GMO, debates around novel crops, and thus consumer acceptance and understanding of the technology.

Our expert survey reveals that there is an emerging consensus that the regulatory processes need to innovate to address the challenges resulting from new technical opportunities. Our finding that experts operating in their professional capacity in the context of research and innovation can, and do, find middle ground is positive.

The challenge will be to reconcile any resulting consensus with the divergent views held based on where one lives. Experts think the key to realizing genome editing’s potential is in regulatory transparency and open dialogue but the notion that an open dialogue with society on genome editing will lead to greater understanding needs to be validated, as recent structured dialogues have not led to greater acceptance or use.

Read the original post

Outbreak
Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
a a b b a f ac a

Video: Death by COVID: The projected grim toll in historical context

The latest statistics, as of July 10, show COVID-19-related deaths in U.S. are just under 1,000 per day nationally, which is ...
mag insects image superjumbo v

Disaster interrupted: Which farming system better preserves insect populations: Organic or conventional?

A three-year run of fragmentary Armageddon-like studies had primed the journalism pumps and settled the media framing about the future ...
dead bee desolate city

Are we facing an ‘Insect Apocalypse’ caused by ‘intensive, industrial’ farming and agricultural chemicals? The media say yes; Science says ‘no’

The media call it the “Insect Apocalypse”. In the past three years, the phrase has become an accepted truth of ...
types of oak trees

Infographic: Power of evolution? How oak trees came to dominate North American forests

Over the course of some 56 million years, oaks, which all belong to the genus Quercus, evolved from a single undifferentiated ...
biotechnology worker x

Can GMOs rescue threatened plants and crops?

Some scientists and ecologists argue that humans are in the midst of an "extinction crisis" — the sixth wave of ...
food globe x

Are GMOs necessary to feed the world?

Experts estimate that agricultural production needs to roughly double in the coming decades. How can that be achieved? ...
eating gmo corn on the cob x

Are GMOs safe?

In 2015, 15 scientists and activists issued a statement, "No Scientific consensus on GMO safety," in the journal Environmental Sciences ...
Screen Shot at PM

Charles Benbrook: Agricultural economist and consultant for the organic industry and anti-biotechnology advocacy groups

Independent scientists rip Benbrook's co-authored commentary in New England Journal calling for reassessment of dangers of all GMO crops and herbicides ...
Screen Shot at PM

ETC Group: ‘Extreme’ biotechnology critic campaigns against synthetic biology and other forms of ‘extreme genetic engineering’

The ETC Group is an international environmental non-governmental organization (NGO) based in Canada whose stated purpose is to monitor "the impact of emerging technologies and ...
Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend